Decoy Therapeutics Corrects Press Release on Warrant Inducement Transaction
Decoy Therapeutics, Inc. has issued a correction to its press release dated September 22, 2026, concerning the company's warrant inducement transaction. The original release contained inaccurate information.
HOUSTON – Decoy Therapeutics, Inc. (NASDAQ: DCOY) has corrected a press release issued on September 22, 2026, which announced the company's warrant inducement transaction. The original announcement contained incorrect details.
The company stated that the correction is necessary to ensure accurate and up-to-date information is provided to investors and the market. Specific details of the correction were not elaborated upon in the statement.
Decoy Therapeutics is a biotechnology company focused on developing novel therapeutic antibodies.
The corrected press release has been made available on the company's investor relations portal.